MSC303
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MSC303, covering 2025-06-11 to 2025-06-11. Get the full timeline:
Most recent: Clinical Trial Update: MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease. [Phase 1, Phase 2]